Cladribine Intravenous and Recombinate
Determining the interaction of Cladribine Intravenous and Recombinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cladribine
Brand name: Mavenclad, Leustatin
Synonyms: Cladribine
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cladribine Intravenous-Recombinate recombinant
- Cladribine Intravenous-Recombivax
- Cladribine Intravenous-Recombivax HB
- Cladribine Intravenous-Recombivax HB Adult
- Cladribine Intravenous-Recombivax HB Dialysis Formulation
- Cladribine Intravenous-Recombivax HB Pediatric/Adolescent
- Recombinate-Cladribine Tablets
- Recombinate-Claforan
- Recombinate-Claforan in D5W
- Recombinate-Claravis
- Recombinate-Clarifoam EF
- Recombinate-Clarinex